Lactobacillus bulgaricus B-30892 for Neurological Conditions

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for neurological conditions and diseases, such as autism, obsessive compulsive disorder, and multiple sclerosis, primarily focus on managing symptoms with drugs that interact with the serotonin system, but these do not address the root cause of autoimmune reactions and neurotoxins affecting the nervous system.

Innovation Solution

Administering an effective amount of Lactobacillus bulgaricus B-30892 or its supernatant to neutralize antigenic and toxic substances, reducing antibody production, and interfering with neurotoxins and autoimmune responses, thereby preventing or mitigating neurological conditions and diseases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If drugs that interact with the serotonin system are used to treat neurological conditions, then symptoms can be managed, but the root cause of autoimmune reactions and neurotoxins is not addressed

Engineering Contradiction:
Improvesymptom managementVSAvoidroot cause treatment
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent extracts and eliminates the harmful bacteria and neurotoxins from the gastrointestinal tract using probiotics and antibiotics, rather than merely managing symptoms. This removes the root cause of autoimmune reactions and neurological conditions, addressing the fundamental problem rather than just treating manifestations.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies preliminary action by using probiotics to restore healthy gut flora and eliminate pathogenic bacteria before neurological damage occurs or worsens. This preventive approach addresses the root cause early in the disease process, preventing the development of full-blown neurological conditions rather than treating established symptoms.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If probiotics are used to improve neurological behavior, then neurological symptoms can be improved, but the mechanism of action is not fully understood

Engineering Contradiction:
Improveneurological symptom improvementVSAvoidmechanism understanding
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent identifies the gut-brain axis as an intermediary system connecting gastrointestinal health to neurological function. Probiotics act as mediators that restore balance in the gut microbiome, which in turn influences neurological conditions through this axis. This provides a plausible mechanism for how probiotics improve neurological symptoms without requiring complete understanding of all underlying pathways.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of Lactobacillus bulgaricus B-30892 has shown to improve neurological symptoms by neutralizing toxins and reducing autoimmune responses, providing a potential treatment for conditions like autism, obsessive compulsive disorder, and multiple sclerosis without suppressing the immune system.

Implementation Method 1

Administering an effective amount of Lactobacillus bulgaricus B-30892 or its supernatant to neutralize antigenic and toxic substances

Methodology Applied
Scientific EffectNeutralization:

Implementation Method 2

reducing antibody production, and interfering with neurotoxins and autoimmune responses

Methodology Applied
Scientific EffectImmunomodulation:

Data Source

PatentUS10363279B2Treatment and prophylaxis for neurological conditions and diseases
Publication Date: 2019.07.30 NUBIOME

AI summary

An embodiment is a method of preventing, mitigating or treating neurological conditions and diseases that includes administering an effective amount of a medicament comprised of Lactobacillus bulgaricus B-30892 and/or a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 and/or bioactive materials resulting from culturing Lactobacillus bulgaricus B-30892 to a human to prevent, mitigate or treat neurological conditions and diseases.